IPO Announced
ADARx Pharmaceuticals IPO
US$446m raised
Lodged 24 Sep 2026 · NASDAQ: ADRX · US$17.00 cash per share
Advisers
Lead managers
- Underwriter
- Legal adviser
- Issuer
- ADARx Pharmaceuticals
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Generate Biomedicines IPO Feb 2026 · US$400m · Biotech
- Kardigan IPO Jun 2026 · US$400m · Biotech
- Candid Therapeutics placement Mar 2026 · US$505m · Biotech
- Korsana Biosciences placement Apr 2026 · US$380m · Biotech
- Braveheart Bio IPO Aug 2026 · US$383m · Biotech
Sources
- Sep 2026 Latham Advises on ADARx Pharmaceuticals Upsized Initial Public Offering lw.com
- 28 Sep 2026 Final IPO prospectus (424B4), ADARx Pharmaceuticals, Inc. sec.gov


